Clinical trial
N-3 Fatty Acids as the First-line Antidepressant Therapy: From Biomarkers to Clinical Subtypes
NCT03871088 is registered in ClinicalTrials.gov with National Science and Technology Council, Taiwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- N-3 Fatty Acids as the First-line Antidepressant Therapy: From Biomarkers to Clinical Subtypes
- Lead sponsor
- National Science and Technology Council, Taiwan
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2015
- Completion date
- December 31, 2018
- Enrollment
- 400 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.